top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xtant Medical Holdings, Inc. Common Stock (NY:XTNT)

0.3312 -0.0127 (-3.69%)
Streaming Delayed Price Updated: 9:32 AM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xtant Medical Holdings, Inc. Common Stock

< Previous 1 2 3 Next >
Which stocks have an unusual volume on Wednesday? ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
Friday's session: top gainers and losers ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Earnings Preview For Xtant Medical Hldgs ↗
 
Via Benzinga
News headline image
Earnings Preview For Xtant Medical Hldgs ↗
 
Via Benzinga
News headline image
Xtant Medical (XTNT) Q2 2026 Earnings Call Transcript ↗
CEO Browne discusses integration challenges and HEMOBLAST transition amid margin pressures. 
Via The Motley Fool
Topics Earnings
News headline image
Xtant Medical Q1 Earnings Call Highlights ↗
Xtant Medical (NYSEAMERICAN:XTNT) raised its full-year 2026 revenue guidance after announcing a distribution agreement that moves the company into the hemostatic agent market, while first-quarter... 
Via MarketBeat
Topics Earnings
News headline image
Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity
Via TheNewswire.com
News headline image
Earnings Scheduled For May 12, 2025 ↗
 
Via Benzinga
News headline image
A Glimpse of Xtant Medical Hldgs's Earnings Potential ↗
 
Via Benzinga
News headline image
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant™ Medical Holdings, Inc.
From Companion Spine
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Xtant Medical Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Xtant Medical Hldgs's Earnings Outlook ↗
 
Via Benzinga
News headline image
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
Via ACCESSWIRE
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
Via ACCESS Newswire
News headline image
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
Via ACCESSWIRE
News headline image
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
Via ACCESSWIRE
News headline image
Earnings Scheduled For March 6, 2025 ↗
 
Via Benzinga
News headline image
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
Via ACCESSWIRE
News headline image
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q2 2024 ↗
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page